Can 18F-FDG-Positron Emission Tomography (FDG-PET) be a Prognostic Tool in Children With Rhabdomyosarcoma Treated With Definitive Radiotherapy?
Cheriyalinkal Parambil BadiraSneha ShahMaya PrasadTushar VoraSiddhartha LaskarNehal KhannaSajid QureshiMukta RamadwarSeema KembhaviHari SankaranVenkatesh RangarajanSonali ThakurGirish ChinnaswamyPublished in: Journal of pediatric hematology/oncology (2022)
Persistent metabolic activity in residual disease post-chemoradiotherapy in RMS may portend a poorer prognosis with an increased risk of relapse. This subset of high-risk patients needs to be identified, and further trials are warranted to develop strategies to improve their outcomes.
Keyphrases
- positron emission tomography
- computed tomography
- pet ct
- pet imaging
- locally advanced
- end stage renal disease
- newly diagnosed
- ejection fraction
- early stage
- young adults
- peritoneal dialysis
- prognostic factors
- squamous cell carcinoma
- type diabetes
- adipose tissue
- patient reported outcomes
- skeletal muscle
- insulin resistance
- free survival
- patient reported